Ocular Pain Market: By Medical Conditions & By Geography - Forecast 2016-2021

  • ID: 3973904
  • Report
  • 132 pages
  • IndustryARC
1 of 3
Ocular pain is also known as eye pain that occurs on the surface of the eye. Ocular pain is considered as a common medical condition that resolves on its own but, sometimes it creates emergency medical conditions. Globally, technological advancement in diagnostic test and increasing disposable income among population are the prime growth drivers of global Ocular pain market. In addition, emerging economies such as China, India and others, will create new opportunities for global Ocular pain market. However, overdose leads to severe respiratory depression or death is the key restraints for global ocular pain market.

Geographically, Asia-Pacific is considered as an emerging market due to growing market penetration in this region. Increasing disposable income among population is also accounted for the ocular pain treatment market growth in Asia-Pacific countries. Rest of the world (RoW) holds fourth position in the global ocular pain treatment market due to poor economic and health condition in most of the African countries. RoW market growth will be fuelled by extensive increase in healthcare infrastructure in Brazil and Mexico.

This report identifies the ocular pain market size in for the year 2016-2021, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to Ocular Pain market.

This report segments global ocular pain market on the basis of medical condition and regional market as follows:
Global Ocular Pain Market By Medical Conditions: Sinusitis, migraines, traumatic events and glaucoma and Others
This report has been further segmented into major regions, which include detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region. The major countries considered under the Asia-Pacific region are India, China, South Korea and Japan. The major countries considered under the European region are Germany, U.K., France, Italy, Spain and Russia. The major countries considered under the North American region are United States, Canada and Mexico
This report identifies all the major companies operating in the global Ocular Pain market. Some of the major companies’ profiles in detail are as follows:
Sylentis S.A
Bayer AG
InSite Vision Incorporated
Reata Pharmaceuticals, Inc
Kala Pharmaceuticals, Inc
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
Note: Product cover images may vary from those shown
2 of 3
1. Ocular Pain – Market Overview

2. Executive Summary

3. Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.3. Product Benchmarking
3.4. End User Profiling
3.5. Top 5 Financials Analysis

4. Ocular Pain – Market Forces
4.1. Drivers
4.1.1. Technological advancement in diagnostic test
4.1.2. Increasing disposable income among population
4.2. Restrains
4.2.1. Lack of awareness
4.2.2. Improper healthcare facilities
4.3. Opportunities
4.3.1 Emerging Economies
4.4. Challenges
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Degree of Competition

5. Ocular Pain – Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers and Distributors

6. Ocular Pain Market, By Medical Conditions
6.1. Sinusitis
6.2. Migraines
6.3. Traumatic events
6.4. Glaucoma
6.5. Others

7. Ocular Pain Market, By Geography
7.1. Europe
7.1.1. Germany
7.1.2. France
7.1.3. Italy
7.1.4. Spain
7.1.5. Russia
7.1.6. U.K.
7.1.7. Rest of Europe
7.2. Asia Pacific
7.2.1. China
7.2.2. India
7.2.3. Japan
7.2.4. South Korea
7.2.5. Rest of Asia-Pacific
7.3. North America
7.3.1. U.S.
7.3.2. Canada
7.3.3. Mexico
7.4. Rest of the World (RoW)
7.4.1. Brazil
7.4.2. Rest of RoW

8. Ocular Pain – Market Entropy
8.1. Expansion
8.2. Technological Developments
8.3. Merger & Acquisitions, and Joint Ventures
8.4. Supply- Contract

9. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
9.1. Sylentis S.A
9.2. Bayer AG
9.3. InSite Vision Incorporated
9.4. Reata Pharmaceuticals, Inc
9.5. Kala Pharmaceuticals, Inc
9.6. Bristol Meyer Squibb
9.7. Merck and Co.
9.8. Becton Dickinson & Co.
9.9. Abbott Laboratories
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"

10. Appendix
10.1. Abbreviations
10.2. Sources
10.3. Research Methodology
10.4. Bibliography
10.5. Compilation of expert Insights
10.6. Disclaimer
Note: Product cover images may vary from those shown
3 of 3


4 of 3
Note: Product cover images may vary from those shown